Machine Learning Approach for Cardiovascular Death Prediction among Nonalcoholic Steatohepatitis (NASH) Liver
Yasin Fatemi1, Mohsen Nikfar1, Amir Oladazimi1
1Department of Industrial and Systems Engineering, Auburn University, Auburn, AL 36849, USA.
Insights
Cardiovascular disease is a major risk for liver transplant recipients with nonalcoholic steatohepatitis (NASH). Machine learning models identified key risk factors and predicted cardiovascular death, aiding prevention strategies.
Area of Science:
- Transplant medicine
- Cardiology
- Data science
Background:
- Cardiovascular disease (CVD) is the primary cause of death in patients with nonalcoholic steatohepatitis (NASH) undergoing liver transplantation.
- Effective risk stratification and prediction models are crucial for managing post-transplant outcomes.
Purpose of the Study:
- To identify critical risk factors for cardiovascular death in NASH patients post-liver transplant.
- To develop and validate a machine learning-based prediction model for cardiovascular mortality.
Main Methods:
- Utilized the Standard Transplant Analysis and Research (STARE) dataset from the Organ Procurement and Transplantation Network (OPTN).
- Applied Recursive Feature Elimination (RFE) and SelectFromModel (SFM) for feature selection.
- Developed prediction models using algorithms including logistic regression, random forest, XGBoost, support vector machine, Gaussian naïve Bayes, and K-nearest neighbors.
- Employed SHapley Additive exPlanations (SHAP) for model interpretability.
Main Results:
- RFE with a random forest estimator was the optimal feature selection method.
- Key predictors identified include recipient/donor blood type, body mass index, recipient/donor state of residence, serum creatinine, and year of transplantation.
- The XGBoost model demonstrated the highest performance, achieving an accuracy of 0.6909 and an AUC of 0.86.
Conclusions:
- A significant predictive relationship exists between identified features and cardiovascular death in NASH liver transplant recipients.
- The developed XGBoost model offers a valuable tool for predicting cardiovascular mortality.
- Findings can inform clinical decision-making to mitigate cardiovascular complications in this patient population.
Abstract:
Cardiovascular disease is the leading cause of mortality among nonalcoholic steatohepatitis (NASH) patients who undergo liver transplants. In the present study, machine learning algorithms were used to identify important risk factors for cardiovascular death and to develop a prediction model. The Standard Transplant Analysis and Research data were gathered from the Organ Procurement and Transplantation Network. After cleaning and preprocessing, the dataset comprised 10,871 patients and 92 features. Recursive feature elimination (RFE) and select from model (SFM) were applied to select relevant features from the dataset and avoid overfitting. Multiple machine learning algorithms, including logistic regression, random forest, decision tree, and XGBoost, were used with RFE and SFM. Additionally, prediction models were developed using a support vector machine, Gaussian naïve Bayes, K-nearest neighbors, random forest, and XGBoost algorithms. Finally, SHapley Additive exPlanations (SHAP) were used to increase interpretability. The findings showed that the best feature selection method was RFE with a random forest estimator, and the most critical features were recipient and donor blood type, body mass index, recipient and donor state of residence, serum creatinine, and year of transplantation. Furthermore, among all the outcomes, the XGBoost model had the highest performance, with an accuracy value of 0.6909 and an area under the curve value of 0.86. The findings also revealed a predictive relationship between features and cardiovascular death after liver transplant among NASH patients. These insights may assist clinical decision-makers in devising strategies to prevent cardiovascular complications in post-liver transplant NASH patients.
More Related Videos
04:14Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis NASH Resolution
Published on: April 16, 2019
08:49Author Spotlight: Enhancing Graft Viability Assessment Through Quantitative Metrics and Innovative Reservoir Systems
Published on: August 2, 2024
